Pharming Group N.V. Files 6-K with March 13 Press Release
Ticker: PHAR · Form: 6-K · Filed: Mar 13, 2025 · CIK: 1828316
| Field | Detail |
|---|---|
| Company | Pharming Group N.V. (PHAR) |
| Form Type | 6-K |
| Filed Date | Mar 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, press-release, regulatory-update
TL;DR
Pharming Group N.V. dropped a 6-K on 3/13 with a press release - check it out.
AI Summary
Pharming Group N.V. filed a Form 6-K on March 13, 2025, furnishing a press release dated March 13, 2025, as Exhibit 99.1. The filing is for the month of March 2025 and indicates the company is a foreign private issuer filing under the 1934 Act. Pharming Group N.V. is incorporated in the Netherlands and its fiscal year ends on December 31.
Why It Matters
This filing provides an update from Pharming Group N.V. to the SEC, likely containing important business or financial information for investors.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that typically contains press releases or other periodic updates, not usually indicative of immediate high risk.
Key Numbers
- 001-39822 — Commission File Number (Identifies the specific SEC filing record for Pharming Group N.V.)
Key Players & Entities
- Pharming Group N.V. (company) — Registrant
- March 13, 2025 (date) — Press Release Date
- 001-39822 (other) — Commission File Number
- 2333 CR Leiden (location) — Company Address
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to furnish a press release dated March 13, 2025, as Exhibit 99.1, to the U.S. Securities and Exchange Commission.
What is the exact date of the press release furnished with this filing?
The press release furnished with this filing is dated March 13, 2025.
What is the Commission File Number for Pharming Group N.V.?
The Commission File Number for Pharming Group N.V. is 001-39822.
Where are Pharming Group N.V.'s principal executive offices located?
Pharming Group N.V.'s principal executive offices are located at Darwinweg 24, 2333 CR Leiden, The Netherlands.
Does Pharming Group N.V. file annual reports under Form 20-F or Form 40-F?
Pharming Group N.V. files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 13, 2025 regarding Pharming Group N.V. (PHAR).